4 Pharmaceutical Stocks to Buy Now

by Portfolio Grader | June 21, 2013 12:00 pm

The grades of four Pharmaceutical stocks are on the rise this week on Portfolio Grader[1]. Each of these stocks is rated an “A” (“strong buy”) or “B” overall (“buy”).

This week, Johnson & Johnson (NYSE:JNJ[2]) is making solid headway. The company’s rating improves to an A (“strong buy”) from last week’s B (“buy”) rating. Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. In Portfolio Grader’s specific subcategories of Earnings Growth, Earnings Momentum, and Equity, JNJ also gets A’s. At present, the stock has a dividend yield of 2.4%. For more information, get Portfolio Grader’s complete analysis of JNJ stock[3].

This week, Bristol-Myers Squibb (NYSE:BMY[4]) is showing significant improvement as the company’s rating hops from a C (“hold”) to a B (“buy”). Bristol-Myers Squibb is a global company that develops, produces and sells pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of BMY stock[5].

Watson Pharmaceuticals (NYSE:WPI[6]) shows solid improvement this week. The company’s rating rises from a B to an A. Watson develops, manufactures, markets, sells and distributes pharmaceutical products. For more information, get Portfolio Grader’s complete analysis of WPI stock[7].

Repros Therapeutics (NASDAQ:RPRX[8]) improves from a B to an A rating this week. Repros Therapeutics is a development stage biopharmaceutical company focusing on the development of oral small molecule drugs for major unmet medical needs. Shares of RPRX have increased 21.4% over the past month, better than the 1.3% decrease the Nasdaq has seen over the same period of time. For more information, get Portfolio Grader’s complete analysis of RPRX stock[9].

Louis Navellier’s proprietary Portfolio Grader[10] stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here[11].

Endnotes:

  1. Portfolio Grader: https://navelliergrowth.investorplace.com/portfolio-grader/
  2. JNJ: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  3. For more information, get Portfolio Grader’s complete analysis of JNJ stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=JNJ
  4. BMY: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  5. For more information, get Portfolio Grader’s complete analysis of BMY stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=BMY
  6. WPI: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  7. For more information, get Portfolio Grader’s complete analysis of WPI stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=WPI
  8. RPRX: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  9. For more information, get Portfolio Grader’s complete analysis of RPRX stock: https://navelliergrowth.investorplace.com/portfolio-grader/stock-report.html?t=RPRX
  10. Portfolio Grader: https://navelliergrowth.investorplace.com/portfolio-grader/
  11. here: https://navelliergrowth.investorplace.com/portfolio-grader/

Source URL: https://investorplace.com/2013/06/4-pharmaceutical-stocks-to-buy-now-jnj-bmy-wpi-10/

Copyright ©2024 InvestorPlace unless otherwise noted.